Viking Therapeutics (NASDAQ:VKTX) Raised to "Sell" at StockNews.com : vimarsana.com

StockNews.com upgraded shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) to a sell rating in a report issued on Thursday morning. A number of other equities analysts have also weighed in on the company. Oppenheimer upped their price objective on Viking Therapeutics from $116.00 to $138.00 and gave the stock an outperform rating in a […]

Related Keywords

United States , Massachusetts , American , William Blair , Sarah Kathryn Rouan , Charles Schwab Investment Management Inc , American Century Companies Inc , Therapeutics Inc , Maxim Group , Goldman Sachs Group Inc , Securities Exchange Commission , Massachusetts Financial Services Co , Viking Therapeutics , Free Report , Moderate Buy , Get Free Report , Director Sarah Kathryn Rouan , Exchange Commission , Century Companies , Financial Services , Sachs Group , Charles Schwab Investment Management , Schwab Investment Management , Viking Therapeutics Daily , Nasdaq Vktx , Vktx , Medical , Upgrade , Stocknews Com ,